SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge.
Pedro Mondejar-LopezLaura Moreno-GalarragaCristina de Manuel-GomezEnrique Blitz-CastroMaynor Bravo-LopezSilvia GartnerEstela Perez-RuizPilar Caro-AguileraVeronica Sanz-SantiagoAlejandro Lopez-NeyraCarmen Luna-ParedesMiguel Garcia-GonzalezJordi Costa-ColomerMaria Cols-RoigIsabel Delgado-PecellinSilvia Castillo-CorullonMarta Ruiz de Valbuena-MaizPatricia W Garcia-MarcosAntonio J Aguilar-FernandezCarlos Martin-De VicenteMª Verisima Barajas-SanchezOrlando Mesa-MedinaCatalina Bover-BauzàJoan Figuerola-MuletBelen Garcia-AvilesMª Jesus Rodriguez-SaezCarlos Garcia-MaganPatricia Juarez-MarruecosJose Ramon Gutierrez-MartinezIsidoro Cortell-AznarDavid Gomez-PastranaM Valle Velasco-GonzalezM Isabel BarrioSanchez-Solís ManuelOscar Asensio de la CruzMaria Dolores Pastor-ViveroPublished in: Pediatric pulmonology (2023)
Spanish current data indicate that cwCF do not experience higher risks of SARS-CoV-2 infection nor worse health outcomes or sequelae. Changes in patients' basal characteristics, clinical courses, and outcomes were detected across waves. While the pandemic continues, a worldwide monitoring of COVID-19 in pediatric CF patients is needed.